Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TOXIN TYPE-A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Urbach, DR; Hansen, PD; Khajanchee, YS; Swanstrom, LL
      A decision analysis of the optimal initial approach to achalasia: Laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection

      JOURNAL OF GASTROINTESTINAL SURGERY
    2. Verheyden, J; Blitzer, A; Brin, MF
      Other noncosmetic uses of BOTOX

      SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
    3. Morris, JL; Jobling, P; Gibbins, IL
      Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    4. Aoki, KR
      Pharmacology and immunology of botulinum toxin serotypes

      JOURNAL OF NEUROLOGY
    5. Fheodoroff, K; Wissel, J; Entner, T; Freimuller, M
      Measuring outcome in spasticity rehabilitation

      WIENER KLINISCHE WOCHENSCHRIFT
    6. Schnider, P; Moraru, E; Kittler, H; Voller, B; Kranz, G; Auff, E
      Botulinumtoxin in the treatment of focal hyperhidrosis

      WIENER KLINISCHE WOCHENSCHRIFT
    7. Govindaraj, S; Cohen, M; Genden, EM; Costantino, PD; Urken, ML
      The use of acellular dermis in the prevention of Frey's syndrome

      LARYNGOSCOPE
    8. Porta, M; Gamba, M; Bertacchi, G; Vaj, P
      Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    9. Velickovic, M; Benabou, R; Brin, MF
      Cervical dystonia - Pathophysiology and treatment options

      DRUGS
    10. Schnider, P; Moraru, E; Kittler, H; Binder, M; Kranz, G; Voller, B; Auff, E
      Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients

      BRITISH JOURNAL OF DERMATOLOGY
    11. Cai, SW; Singh, BR
      A correlation between differential structural features and the degree of endopeptidase activity of type A botulinum neurotoxin in aqueous solution

      BIOCHEMISTRY
    12. Whitaker, J; Butler, A; Semlyen, JK; Barnes, MP
      Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: A comparative study between a home and a clinic treatment service

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    13. Jensen, R; Olesen, J
      Tension-type headache: an update on mechanisms and treatment

      CURRENT OPINION IN NEUROLOGY
    14. Hanson, MA; Stevens, RC
      Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin typeB at 2.0 angstrom resolution

      NATURE STRUCTURAL BIOLOGY
    15. Kadkhodayan, S; Knapp, MS; Schmidt, JJ; Fabes, SE; Rupp, B; Balhorn, R
      Cloning, expression, and one-step purification of the minimal essential domain of the light chain of botulinum neurotoxin type A

      PROTEIN EXPRESSION AND PURIFICATION
    16. Graham, HK; Aoki, KR; Autti-Ramo, I; Boyd, RN; Delgado, MR; Gaebler-Spira, DJ; Gormley, ME; Guyer, BM; Heinen, F; Holton, AF; Matthews, D; Molenaers, G; Motta, F; Ruiz, PJG; Wissel, J
      Recommendations for the use of botulinum toxin type A in the management ofcerebral palsy

      GAIT & POSTURE
    17. Chaddock, JA; Purkiss, JR; Duggan, MJ; Quinn, CP; Shone, CC; Foster, KA
      A conjugate composed of nerve growth factor coupled to a non-toxic derivative of Clostridium botulinum neurotoxin type A can inhibit neurotransmitterrelease in vitro

      GROWTH FACTORS
    18. Suputtitada, A
      Managing spasticity in pediatric cerebral palsy using a very low dose of botulinum toxin type A - Preliminary report

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    19. Santafe, MM; Urbano, FJ; Lanuza, MA; Uchitel, OD
      Multiple types of calcium channels mediate transmitter release during functional recovery of botulinum toxin type A-poisoned mouse motor nerve terminals

      NEUROSCIENCE
    20. Nelles, G; Diener, HC
      Pharmacological therapy in neurological rehabilitation

      AKTUELLE NEUROLOGIE
    21. Zermann, DH; Ishigooka, M; Schubert, J; Schmidt, RA
      Perisphincteric injection of botulinum toxin type A - A treatment option for patients with chronic prostatic pain?

      EUROPEAN UROLOGY
    22. Delgado, MR; Wilson, H; Johnston, T; Richards, S; Karol, L
      A preliminary report of the use of botulinum toxin type A in infants with clubfoot: Four case studies

      JOURNAL OF PEDIATRIC ORTHOPAEDICS
    23. Brashear, A; Watts, MW; Marchetti, A; Magar, R; Lau, H; Wang, LP
      Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: A retrospective chart review

      CLINICAL THERAPEUTICS
    24. Christiansen, SP; Sandnas, A; Prill, R; Youle, RJ; McLoon, LK
      Acute effects of the skeletal muscle-specific immunotoxin ricin-mAb 35 on extraocular muscles of rabbits

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    25. Schurch, B; Stohrer, M; Kramer, G; Schmid, DM; Gaul, G; Hauri, D
      Botulinum-a toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results

      JOURNAL OF UROLOGY
    26. Richardson, D; Sheean, G; Werring, D; Desai, M; Edwards, S; Greenwood, R; Thompson, A
      Evaluating the role of botulinum toxin in the management of focal hypertonia in adults

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    27. Ishikawa, H; Mitsui, Y; Yoshitomi, T; Mashimo, K; Aoki, S; Mukuno, K; Shimizu, K
      Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles

      JAPANESE JOURNAL OF OPHTHALMOLOGY
    28. Maillard, I; Schweizer, V; Broccard, A; Duscher, A; Liaudet, L; Schaller, MD
      Use of botulinum toxin type A to avoid tracheal intubation or tracheostomyin severe paradoxical vocal cord movement

      CHEST
    29. Hurvitz, EA; Conti, GE; Flansburg, EL; Brown, SH
      Motor control testing of upper limb function after botulinum toxin injection: A case study

      ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
    30. Delgado, MR
      The use of botulinum toxin type A in children with cerebral palsy: a retrospective study

      EUROPEAN JOURNAL OF NEUROLOGY
    31. Koman, LA; Smith, BP; Tingey, CT; Mooney, JF; Slone, S; Naughton, MJ
      The effect of botulinum toxin type A injections on the natural history of equinus foot deformity in paediatric cerebral palsy patients

      EUROPEAN JOURNAL OF NEUROLOGY
    32. Boyd, RN; Graham, HK
      Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy

      EUROPEAN JOURNAL OF NEUROLOGY
    33. Heinen, F; Linder, M; Mall, V; Kirschner, J; Korinthenberg, R
      Adductor spasticity in children with cerebral palsy and treatment with botulinum toxin type A: the parents' view of functional outcome

      EUROPEAN JOURNAL OF NEUROLOGY
    34. Molenaers, G; Desloovere, K; Eyssen, M; Decat, J; Jonkers, I; De Cock, P
      Botulinum toxin type A treatment of cerebral palsy: an integrated approach

      EUROPEAN JOURNAL OF NEUROLOGY
    35. Molenaers, G; Eyssen, M; Desloovere, K; Jonkers, I; De Cock, P
      A multilevel approach to botulinum toxin type A treatment of the (ilio)psoas in spasticity in cerebral palsy

      EUROPEAN JOURNAL OF NEUROLOGY
    36. Link, A; Kabus, C; Haas, J
      Use of spasmography to assess the effects of botulinum toxin type A in patients with lower-limb spasticity

      EUROPEAN JOURNAL OF NEUROLOGY
    37. Thompson, AJ; Richardson, D; Sheehan, G; Desai, M; Werring, D; Edwards, S; Greenwood, R
      Evaluating the role of botulinum toxin type A in adults with focal spasticity

      EUROPEAN JOURNAL OF NEUROLOGY
    38. O'Brien, C
      Management of spasticity with botulinum toxin type A: implementing the treatment algorithm

      EUROPEAN JOURNAL OF NEUROLOGY
    39. Schurch, B; Schmid, DM; Knapp, PA
      An update on the treatment of detrusor-sphincter dyssynergia with botulinum toxin type A

      EUROPEAN JOURNAL OF NEUROLOGY
    40. Ward, AB
      Botulinum toxin type A treatment of hip and thigh spasticity: a technique for injection of psoas major muscle

      EUROPEAN JOURNAL OF NEUROLOGY
    41. Ward, AB
      The use of botulinum toxin type A in spastic diplegia due to cerebral palsy

      EUROPEAN JOURNAL OF NEUROLOGY
    42. Smuts, JA; Baker, MK; Smuts, HM; Stassen, JMR; Rossouw, E; Barnard, PWA
      Prophylactic treatment of chronic tension-type headache using botulinum toxin type A

      EUROPEAN JOURNAL OF NEUROLOGY
    43. Naver, H; Swartling, C; Aquilonius, SM
      Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience

      EUROPEAN JOURNAL OF NEUROLOGY
    44. Guyer, BM
      Botulinum toxin type A: new therapeutic directions

      EUROPEAN JOURNAL OF NEUROLOGY
    45. Atassi, MZ; Oshima, M
      Structure, activity, and immune (T and B cell) recognition of botulinum neurotoxins

      CRITICAL REVIEWS IN IMMUNOLOGY
    46. Mezaki, T; Kaji, R; Brin, MF; Hirota-Katayama, M; Kubori, T; Shimizu, T; Kimura, J
      Combined use of type A and F botulinum toxins for blepharospasm: A double-blind controlled trial

      MOVEMENT DISORDERS
    47. Pandyan, AD; Johnson, GR; Price, CIM; Curless, RH; Barnes, MP; Rodgers, H
      A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity

      CLINICAL REHABILITATION
    48. Wissel, J; Muller, J; Heinen, F; Mall, V; Sojer, M; Ebersbach, G; Poewe, W
      Safety and tolerance of a single dose of botulinum toxin type A in patients with local spasticity-associated problems: A prospective open multicenterstudy comprising 204 patients

      WIENER KLINISCHE WOCHENSCHRIFT
    49. Matarasso, A; Matarasso, SL; Brandt, FS; Bellman, B
      Botulinum A exotoxin for the management of platysma bands

      PLASTIC AND RECONSTRUCTIVE SURGERY
    50. Lacy, DB; Stevens, RC
      Sequence homology and structural analysis of the clostridial neurotoxins

      JOURNAL OF MOLECULAR BIOLOGY
    51. Lalli, G; Herreros, J; Osborne, SL; Montecucco, C; Rossetto, O; Schiavo, G
      Functional characterisation of tetanus and botulinum neurotoxins binding domains

      JOURNAL OF CELL SCIENCE
    52. Neale, EA; Bowers, LM; Jia, M; Bateman, KE; Williamson, LC
      Botulinum neurotoxin a blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal

      JOURNAL OF CELL BIOLOGY
    53. Raciborska, DA; Charlton, MP
      Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) inneuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    54. Al-Khodairy, AT; Gobelet, C; Rossier, AB
      Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?

      SPINAL CORD
    55. SCHURCH B
      WHAT IS NEW IN DETRUSOR-SPHINCTER DYSSYNERGIA TREATMENT IN SPINAL-CORD INJURY PATIENTS

      NeuroRehabilitation
    56. Eleopra, R; Tugnoli, V; Rossetto, O; De Grandis, D; Montecucco, C
      Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans

      NEUROSCIENCE LETTERS
    57. DOGGWEILER R; ZERMANN DH; ISHIGOOKA M; SCHMIDT RA
      BOTOX-INDUCED PROSTATIC INVOLUTION

      The Prostate
    58. JITPIMOLMARD S; TIAMKAO S; LAOPAIBOON M
      LONG-TERM RESULTS OF BOTULINUM TOXIN TYPE-A (DYSPORT) IN THE TREATMENT OF HEMIFACIAL SPASM - A REPORT OF 175 CASES

      Journal of Neurology, Neurosurgery and Psychiatry
    59. Naumann, M; Toyka, KV; Taleghani, BM; Ahmadpour, J; Reiners, K; Bigalke, H
      Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    60. MAKSYMOWYCH AB; SIMPSON LL
      BINDING AND TRANSCYTOSIS OF BOTULINUM NEUROTOXIN BY POLARIZED HUMAN COLON-CARCINOMA CELLS

      The Journal of biological chemistry
    61. ANGAUTPETIT D; MOLGO J; FAILLE L; JUZANS P; TAKAHASHI M
      INCORPORATION OF SYNAPTOTAGMIN-II TO THE AXOLEMMA OF BOTULINUM TYPE-APOISONED MOUSE MOTOR ENDINGS DURING ENHANCED QUANTAL ACETYLCHOLINE-RELEASE

      Brain research
    62. SHAPIRO RL; HATHEWAY C; SWERDLOW DL
      BOTULISM IN THE UNITED-STATES - A CLINICAL AND EPIDEMIOLOGIC REVIEW

      Annals of internal medicine
    63. DAELEN B; THORWIRTH V; KOCH A
      TREATMENT OF RECURRENT DISLOCATION OF THE TEMPOROMANDIBULAR-JOINT WITH TYPE-A BOTULINUM TOXIN

      International journal of oral and maxillofacial surgery
    64. PINHO SMR; TSUJI DH; SENNES L; MENEZES M
      PARADOXICAL VOCAL FOLD MOVEMENT - A CASE-REPORT

      Journal of voice
    65. SAMPAIO C; FERREIRA JJ; SIMOES F; ROSAS MJ; MAGALHAES M; CORREIA AP; BASTOSLIMA A; MARTINS R; CASTROCALDAS A
      DYSBOT - A SINGLE-BLIND, RANDOMIZED PARALLEL STUDY TO DETERMINE WHETHER ANY DIFFERENCES CAN BE DETECTED IN THE EFFICACY AND TOLERABILITY OF2 FORMULATIONS OF BOTULINUM TOXIN TYPE-A - DYSPORT AND BOTOX - ASSUMING A RATIO OF 4 1/

      Movement disorders
    66. LEWITT PA; TROSCH RM
      IDIOSYNCRATIC ADVERSE REACTIONS TO INTRAMUSCULAR BOTULINUM TOXIN TYPE-A INJECTION

      Movement disorders
    67. DAELEN B; THORWIRTH V; KOCH A
      NEUROGENIC DISLOCATION OF THE TEMPOROMAND IBULAR-JOINT DEFINITION ANDTHERAPY WITH BOTULINUM TOXIN

      Nervenarzt
    68. CHEN F; KUZIEMKO GM; AMERSDORFER P; WONG C; MARKS JD; STEVENS RC
      ANTIBODY MAPPING TO DOMAINS OF BOTULINUM NEUROTOXIN SEROTYPE-A IN THECOMPLEXED AND UNCOMPLEXED FORMS

      Infection and immunity
    69. JUZANS P; COMELLA JX; MOLGO J; FAILLE L; ANGAUTPETIT D
      NERVE-TERMINAL SPROUTING IN BOTULINUM TYPE-A TREATED MOUSE LEVATOR AURIS LONGUS MUSCLE

      Neuromuscular disorders
    70. INAGI K; FORD CN; BLESS DM; HEISEY D
      ANALYSIS OF FACTORS AFFECTING BOTULINUM TOXIN RESULTS IN SPASMODIC DYSPHONIA

      Journal of voice
    71. GALLIVAN GJ; HOFFMAN L; GALLIVAN KH
      EPISODIC PAROXYSMAL LARYNGOSPASM - VOICE AND PULMONARY-FUNCTION ASSESSMENT AND MANAGEMENT

      Journal of voice
    72. JANKOVIC J; SCHWARTZ K; CLEMENCE W; ASWAD A; MORDAUNT J
      A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE BOTULINUM TOXIN TYPE-A IN ESSENTIAL HAND TREMOR

      Movement disorders
    73. GREENE PE; FAHN S
      RESPONSE TO BOTULINUM TOXIN-F IN SERONEGATIVE BOTULINUM TOXIN A-RESISTANT PATIENTS

      Movement disorders
    74. ERBGUTH F; CLAUS D
      TREATMENT OF PATHOLOGICAL MUSCULAR OVERCO NTRACTIONS WITH LOCAL INJECTIONS OF BOTULINUM TOXIN TYPE-A

      Nervenheilkunde
    75. CANALS JM; RUIZAVILA L; CANTI C; SOLSONA C; MARSAL J
      FUNCTIONAL RECONSTITUTION OF KCL-EVOKED, CA2-DEPENDENT ACETYLCHOLINE-RELEASE SYSTEM IN XENOPUS OOCYTES MICROINJECTED WITH PRESYNAPTIC PLASMA-MEMBRANES AND SYNAPTIC VESICLES()

      Journal of neuroscience research
    76. MAURIELLO JA; LEONE T; DHILLON S; PAKEMAN B; MOSTAFAVI R; YEPEZ MC
      TREATMENT CHOICES OF 119 PATIENTS WITH HEMIFACIAL SPASM OVER 11 YEARS

      Clinical neurology and neurosurgery
    77. RAMPES H; PATEL AG
      NEUROLEPTIC-INDUCED BLEPHAROSPASM AND ITS TREATMENT WITH BOTULINUM TOXIN TYPE-A

      Irish journal of psychological medicine
    78. IWASHIGE H; NEMETO Y; TAKAHASHI H; MARUO T
      BOTULINUM TOXIN TYPE-A PURIFIED NEUROTOXIN COMPLEX FOR THE TREATMENT OF BLEPHAROSPASM - A DOSE-RESPONSE STUDY MEASURING EYELID FORCE

      Japanese Journal of Ophthalmology
    79. POLO KB; JABBARI B
      EFFECTIVENESS OF BOTULINUM TOXIN TYPE-A AGAINST PAINFUL LIMB MYOCLONUS OF SPINAL-CORD ORIGIN

      Movement disorders
    80. SCHMIDT KH; WIESNER J; GERLACH D; REICHARDT W; OZEGOWSKI JH; KOHLER W
      SUSCEPTIBILITY OF CHICKEN EMBRYOS TO GROUP-A STREPTOCOCCI - CORRELATION WITH FIBRINOGEN BINDING

      FEMS immunology and medical microbiology
    81. GREENE PE; FAHN S
      USE OF BOTULINUM TOXIN TYPE-F INJECTIONS TO TREAT TORTICOLLIS IN PATIENTS WITH IMMUNITY TO BOTULINUM TOXIN TYPE-A

      Movement disorders
    82. ARRIBAS M; BLASI J; EGEA G; FARINAS I; SOLSONA C; MARSAL J
      HIGH-RESOLUTION LABELING OF CHOLINERGIC NERVE-TERMINALS USING A SPECIFIC FULLY ACTIVE BIOTINYLATED BOTULINUM NEUROTOXIN TYPE-A

      Journal of neuroscience research
    83. BUSLAU M; KAPPUS R; GERLACH D; KOHLER W; DIEHL S; HOLZMANN H
      STREPTOCOCCAL AND STAPHYLOCOCCAL SUPERANTIGENS (ETA, SEB) - PRESENTATION BY HUMAN EPIDERMAL-CELLS AND INDUCTION OF AUTOLOGOUS T-CELL PROLIFERATION INVITRO

      Acta dermato-venereologica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 06:29:32